Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03095612
Brief Title: Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)

First Submitted : March 23, 2017
First Submitted that Met QC Criteria : March 23, 2017
First Posted : March 29, 2017

Last Update Submitted that Met QC Criteria : September 6, 2019
Last Update Posted : September 9, 2019